Overview

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

Status:
Recruiting
Trial end date:
2022-07-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of repeated doses of cefiderocol on the PK of midazolam.
Phase:
Phase 1
Details
Lead Sponsor:
Shionogi
Treatments:
Midazolam